FDA approves USGI Medical’s pivotal study of the POSE2.0 procedure for primary obesity
The FDA has approved an USGI Medical’s Investigational Device Exemption application to conduct a pivotal study of its POSE2.0...
FDA approves USGI Medical’s pivotal study of the POSE2.0 procedure for primary obesity
Journal Watch 31/01/2024
How obesity dismantles mitochondria, the key mechanism behind obesity-related metabolic dysfunction
New way of fasting may protect against inflammation
Obesity and alcohol are contributing to increases in CRC rates among young adults
Bariatric surgery can impair midwall left ventricular dysfunction in certain patients one-year after surgery
Perioperative risk should not be a main deciding factor in the choice of procedure